ADAGE CAPITAL PARTNERS GP, L.L.C.
Q2 2023 13F-HR Holdings
Net value change ($000)
+1,441,475
(3.2%)
New positions
106
Sold out positions
141
Turnover %
8.1%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 385,227 | 17.9% |
| AAPL | 375,819 | 15.7% |
| NVDA | 357,944 | 50.6% |
| AMZN | 269,730 | 27.8% |
| RBA | 190,745 | NEW |
| DPZ | 182,260 | 1559.1% |
| BA | 181,993 | 70.9% |
| META | 160,827 | 34.1% |
| TSLA | 146,041 | 27.4% |
| REATA PHARMACEUTICALS INC | 137,370 | 321.7% |
Top Reduces (Value $000, Stocks/ETFs)
| CMG | -175,989 | -89.3% |
| RBA | -169,835 | -100.0% |
| XOM | -151,575 | -24.3% |
| KEY | -147,906 | -70.8% |
| DOV | -143,537 | -63.9% |
| SHAW COMMUNICATIONS INC | -137,366 | -100.0% |
| CXT | -123,638 | -100.0% |
| TVTX | -92,523 | -100.0% |
| Provention Bio, Inc. | -87,748 | -100.0% |
| CMA | -86,598 | -67.1% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
39,699
(0.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|